elacridar has been researched along with Cancer of Prostate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corcoran, C; Devery, A; Dowling, C; Fan, Y; Fitzpatrick, JM; Gallagher, WM; Mulrane, L; O'Connor, D; O'Connor, R; O'Driscoll, L; O'Neill, AJ; Prencipe, M; Rani, S; Watson, RW | 1 |
1 other study(ies) available for elacridar and Cancer of Prostate
Article | Year |
---|---|
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Galactosidase; Cell Line, Tumor; Cell Survival; Cellular Senescence; Docetaxel; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Genes, Reporter; Humans; Luciferases, Renilla; Male; Molecular Targeted Therapy; NF-kappa B; Nitriles; Prostatic Neoplasms; Sulfones; Taxoids; Tetrahydroisoquinolines | 2011 |